Solid Dose Manufacturing

INSIGHTS ON SOLID DOSE MANUFACTURING

Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design
Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.
From Early Development To Commercial Launch: An End-To-End Partnership
Bringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.
Safely Scaling High Potency API Manufacturing
Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.
Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications
More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

Navigating The Development Of Dry Powder For Inhalation
9/9/2026

A CDMO-authored framework for navigating dry powder inhaler development, covering target product profile definition, API characterization, particle engineering technology selection, and encapsulation considerations.
How Dosage Form Decisions Shape Pediatric And Geriatric Drug Development
8/27/2026

Developing pediatric and geriatric pharmaceuticals requires customized strategies beyond tablet crushing, balancing specific age-related palatability, packaging, real-world administration, and lifecycle management needs for optimal patient outcomes.
5 Questions To Ask Before Selecting A High-Containment Isolator
10/29/2026

Containment performance alone does not settle isolator selection. Workflow fit, operator ergonomics, transfer and cleaning, and long-term operation each shape whether a system works in practice.
Single-Use Containment And Oral Solid Dosage (OSD)
9/16/2026

Flexible single-use containment systems achieve sub-microgram exposure levels while eliminating cleaning validation downtime for high-potency oral solid dose manufacturing.
Reducing Uncertainty In Early Oral Drug Development
8/31/2026

Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.

Pharmacon™ Downflow Booth Generation 3

Esco Pharma's Downflow Booth Generation 3 (DFBG3) is a new generation of Esco powder containment booth which provides simplicity with assured quality.
Loading And Charging Of Drums For High Potent API's: IsoTube

Isotube is an effective option for the safe loading and charging of multiple drums of HPAPIs. Compared to the DCS® Drum Containment System for safely discharging drums, it is the preferred choice when charging lumpy and agglomerated products as a lump breaker system can be included in the lower part of the discharge hopper.
Containment: Bag In Bag Out

The DoverPac® Bag In/Bag Out (BIBO) containment system is a family of contained transfer designs for multiple processes. The primary components for this validated operation consist of multiple groove canisters, docking interface hardware, and softgoods in either continuous liner form or discreet liners.
Single Use Containment Systems For Biopharmaceutical Powders

ILC Dover is 100% focused on containing your process to get your product to market fast, safe, and pure. Our single-use containment solutions leverage our patented and industry-leading ArmorFlex^® films to deliver extreme durability for a lower cost.
From Formulation To Global Supply: Mastering Oral Solid Development

A global, integrated approach to oral solid dosage development combines formulation science, advanced delivery, and scalable manufacturing to support efficient clinical progress and reliable supply.